Clinical Trial Update: Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oxybutynin for hot flashes in men undergoing hormone therapy for prostate cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• oxybutynin (oxybutynin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-03-30